-
Intermedji Farmaċewtiċi |Immunoloġija |Sintesi tal-peptidi |Aċidu Amminiku naturali |Fmoc-N-Me-Trp(Boc)-OH |Nru CAS: 197632-75-0
Manifattura professjonali u provvista bijofarmaċewtika |Materja Prima |Reaġenti Farmaċewtiċi Intermedji |Immunoloġija |Sintesi tal-peptidi |Aċidu Amminiku naturali |Fmoc-N-Me-Trp(Boc)-OH |CAS:197632-75-0 |C32H32N2O6
-
Intermedji Farmaċewtiċi |Immunoloġija |Sintesi tal-peptidi |Fmoc-Trp-OH |Nru CAS:35737-15-6 |C26H22N2O4
Manifattura professjonali u provvista bijofarmaċewtika |Materja Prima |Reaġenti Farmaċewtiċi Intermedji |Immunoloġija |Sintesi tal-peptidi |Aċidu Amminiku naturali |Fmoc-Trp-OH |CAS:35737-15-6 |C26H22N2O4
-
Intermedji Farmaċewtiċi |Immunoloġija |Sintesi tal-peptidi |Fmoc-His(Trt)-OH |Nru CAS:109425-51-6 |C40H33N3O4
Manifattura professjonali u provvista bijofarmaċewtika |Materja Prima |Reaġenti Farmaċewtiċi Intermedji |Immunoloġija |Sintesi tal-peptidi |Aċidu Amminiku naturali |Fmoc-His(Trt)-OH |CAS:109425-51-6 |C40H33N3O4
-
Intermedji Farmaċewtiċi |Immunoloġija |Sintesi tal-peptidi |Fmoc-Lys(Boc)-OH |CAS Nru.:71989-26-9
Manifattura professjonali u provvista bijofarmaċewtika |Materja Prima |Reaġenti Farmaċewtiċi Intermedji |Immunoloġija |Sintesi tal-peptidi |Aċidu Amminiku naturali |Fmoc-Lys(Boc)-OH |CAS:71989-26-9 |C26H32N2O6
-
Fmoc-D-Trp(Boc)-OH 163619-04-3
Manifattura professjonali u provvista bijofarmaċewtika |Materja Prima |Reaġenti Farmaċewtiċi Intermedji |Immunoloġija |Sintesi tal-peptidi |Aċidu Amminiku naturali |Fmoc-D-Trp(Boc)-OH |CAS:163619-04-3 |C31H30N2O6
-
Intermedji Farmaċewtiċi |Mard respiratorju |Pranlukast Intermedji |3′-Acetylamino-2′-hydroxyacetophenone |CAS Nru.103205-33-0
Manifattura professjonali u provvista bijofarmaċewtika |Reaġenti Farmaċewtiċi Intermedji |Materja prima |Mard respiratorju |Pranlukast Intermedji |3′-Acetylamino-2′-hydroxyacetophenone |CAS:103205-33-0 |C10H11NO3
-
Intermedji Farmaċewtiċi |Dabigatran Intermedji |N-(4-CYANO-FENIL)-GLIĊINA |CAS Nru.42288-26-6
Manifattura professjonali u provvista bijofarmaċewtika |Reaġenti Farmaċewtiċi Intermedji |Materja prima |Antikoagulanti API |Dabigatran Intermedji |N-(4-CYANO-FENIL)-GLIĊINA |CAS:42288-26-6 |C9H8N2O2
-
Intermedji Farmaċewtiċi |Antagonist tal-integra |Lifitegrast Intermedji |3-Bromo-L-phenylalanine |CAS Nru.82311-69-1
Manifattura professjonali u provvista bijofarmaċewtika |Materja Prima |Intermedji Farmaċewtiċi |Lifitegrast Intermedji |3-Bromo-L-phenylalanine |CAS:82311-69-1 |C9H10BrNO2
-
Intermedji Farmaċewtiċi |Antagonist tal-integra |Lifitegrast Intermedji |Boc-3-bromo-L-phenylalanine |CAS Nru.82278-73-7
Manifattura professjonali u provvista bijofarmaċewtika |Materja Prima |Intermedji Farmaċewtiċi |Antagonist tal-integra |Lifitegrast Intermedji |Boc-3-bromo-L-phenylalanine |CAS:82278-73-7 |C14H18BrNO4
-
Materja Prima Farmaċewtika u Intermedji |Dijabete |(R)-3-Aminopiperidine dihydrochloride |CAS Nru.334618-23-4
Manifattura professjonali u provvista bijofarmaċewtika |Materja Prima |Ingredjent Farmaċewtiku Attiv Intermedji |Dijabete |(R)-3-Aminopiperidine dihydrochloride |CAS:334618-23-4 |C5H14Cl2N2
-
Intermedji Farmaċewtiċi |(R)-1-Boc-3-Aminopiperidine |Dijabete |CAS:188111-79-7
Manifattura professjonali u provvista bijofarmaċewtika |Materja Prima |Reaġenti Farmaċewtiċi Intermedji |Intermedji Farmaċewtiċi |(R)-1-Boc-3-Aminopiperidine |CAS:188111-79-7 |C10H20N2O2
-
Materja Prima |Intermedji Farmaċewtiċi |Kardjovaskulari |Mard |Aċidu (S)-(-)-Indoline-2-carboxylic |CAS Nru.79815-20-6
Manifattura professjonali u provvista bijofarmaċewtika |Materja Prima |Reaġenti Farmaċewtiċi Intermedji |Mard Kardjovaskulari |Pressjoni Għolja tad-Demm |Aċidu (S)-(-)-Indoline-2-carboxylic |CAS:79815-20-6 |C9H9NO2